medigraphic.com
ISSN 0028-3851 (Print)

2018, Number 1

<< Back Next >>

Rev Neurol Neurocir Psiquiat 2018; 46 (1)

Concept and evolution of alcohol dependence disorder

Souza MM

Language: Spanish
References: 157
Page: 14-30
PDF size: 280.91 Kb.


ABSTRACT

The disorder of dependence on alcohol is reviewed (DDA), often extended to other (legal and illegal) substances consumed by prescription or selfmedication. Displays brief epidemiological overview; a historical sightsee of the dependency, stands the self-knowledge and self-acceptance of disorders in dual patients. It’s designated the stigma as a barrier to their recovery and some of its alterations not appreciated by mutual aid groups, emphasizes the prevalence of joint with the personality disorder that establishes the dual pathology and the absence of an “addictive personality”. It is concluded with the recognition of the targeted efforts and the importance of the TPDA and its comorbidity as a problem of public health for the sake of the rehabilitation and social reintegration.


REFERENCES

  1. Nelson DE, Jarman DW, Rehm J, Greenfield TK, Rey G, Kerr WC et al. Alcohol-attributable cancer deaths and years of potential life lost in the United States. Am J Public Health. 2013; 103 (4): 641-648.

  2. Rehm J, Shield KD, Joharchi N, Shuper PA. Alcohol consumption and the intention to engage in unprotected sex: systematic review and meta-analysis of experimental studies. Addiction. 2012; 107 (1): 51-59.

  3. Souza y Machorro M. Trastorno por dependencia del alcohol y trastornos de la personalidad. México: Editorial Fondo de Cultura Económica; 2017. En revisión.

  4. WHO. Global status report on alcohol and health. Geneva: World Health Organization; 2014a.

  5. WHO. Global strategy. To reduce the harmful use of alcohol. Geneva: World Health Organization; 2014b.

  6. WHO. Mental health action plan 2013-2020. Geneva: World Health Organization; 2013.

  7. Souza y Machorro M. Psiquiatría de las adicciones. México: Editorial Fondo de Cultura Económica; 2010.

  8. EMCDDA. Selected issue 2011: Guidelines for the treatment of drug dependence: a European perspective, Selected issue, European Monitoring Centre for Drugs and Drug Addiction. Lisbon, Portugal, 2011. Rev. Agosto, 2017.

  9. Souza y Machorro M. De la resiliencia a la reintegración social del paciente dual. Seminario “Prevención y rehabilitación de las adicciones”. Maestría en Psicoterapia de las Adicciones. Colegio Internacional de Educación Superior, CIES/SEP. México, D.F. Mayo 31, 2015.

  10. WHO. Measures: social reintegration. Criminal and noncriminal measures: social reintegration. New York: World Health Organization; 2006. Rev. Agosto, 2017.

  11. Poznyak V, Fleischmann A, Rekve D, Rylett M, Rehm J, Gmel G. The world health organization’s global monitoring system on alcohol and health. Alcohol Res. 2013; 35 (2): 244-249.

  12. Souza y Machorro M. Patología dual: aspectos clínicos y terapéuticos de la comorbilidad adictiva. México: Difusión y Tecnología S.A. de C.V.; 2011.

  13. Karam-Hage M, Nerenberg L, Brower KJ. Modifying residents’ professional attitudes about substance abuse treatment and training. Am J Addict. 2001; 10 (1): 40-47.

  14. Westreich LM. Diagnosing and treating substance use disorders in general psychiatry. Addiction, Substance Use Disorder. AAPA. December 04, 2014.

  15. Souza y Machorro M. Adicciones. Visión integral de su problemática, abordaje y tratamiento (Patología dual). México: Facultad de Medicina, UNAM. Editorial Prado; 2014.

  16. American Medical Association. Medical school education on abuse on alcoholism and other psychoactive drugs. JAMA. 1972; 219 (13): 1746-1749.

  17. World Health Organization. Alcohol related disabilities. Geneva: World Health Organization; 1977. pp. 3-4. (WHO offset publication no. 32)

  18. WHO. Problems related to alcohol consumption. Report of a WHO Expert Commitee Geneva. WHO Technical Report series, No 650. World Health Organization; 1980.

  19. WHO. ICD-10. International Statistical Classification of Diseases and Related Health Problems 10th Revision. Geneva: World Health Organization; 2007.

  20. Schuckit MA, Smith TL, Heron J, Hickman M, Macleod J, Lewis G et al. Testing a level of response to alcohol-based model of heavy drinking and alcohol problems in 1,905 17-year-olds. Alcohol Clin Exp Res. 2011; 35 (10): 1897-1904.

  21. Weinberger AH, Platt J, Goodwin RD. Is cannabis use associated with an increased risk of onset and persistence of alcohol use disorders? A three-year prospective study among adults in the United States. Drug Alcohol Depend. 2016; 161: 363-367.

  22. Leino-Kilpi H, Solante S, Katajisto J. Problems in the outcomes of nursing education create challenges for continuing education. J Contin Educ Nurs. 2001; 32 (4): 183-189.

  23. Souza y Machorro M. Adicciones: clínica y terapéutica. México: Editorial Alfil; 2007.

  24. Guisa CVM, Díaz-Barriga SL, Souza y Machorro M. La educación médica en adicciones y sus problemas. Psiquiatría. 2004b; 20 (1): 9-20.

  25. Anthony JC, Eaton WW, Henderson AS. Psychiatric epidemiology. Epidemiol Rev. 1995; 17 (1): 1-8.

  26. Norquist GS, Regier DA. The epidemiology of psychiatric disorders and the de facto mental health care system. Annu Rev Med. 1996; 47: 473-479.

  27. Merikangas KR, Mehta RL, Molnar BE, Walters EE, Swendsen JD, Aguilar-Gaziola S et al. Comorbidity of substance use disorders with mood and anxiety disorders: results of the International Consortium in Psychiatric Epidemiology. Addict Behav. 1998; 23 (6): 893-907.

  28. Anthony JC. Epidemiology of drug dependence. In: Galanter M, Kleber HD ed. Textbook of substance abuse treatment. 2nd edition. Washington, DC: American Psychiatric Press; 1999. pp. 47-58.

  29. Guisa-Cruz VM, Barriga-Salgado LD, Souza y Machorro M. La dependencia alcohólica en México. Rev Mex Neuroci. 2004b; 5 (4): 356-364.

  30. Souza y Machorro M. Diagnóstico y tratamiento de los síndromes adictivos. México: Ciencia y Cultura Latinoamérica; 2000.

  31. Dalagija-Ramić L, Dvizac Z, Mehić-Basara N. A model of addiction prevention. Med Arh. 2001; 55 (3): 155-156.

  32. Goldstein FJ. DOs need more training in diagnosing and treating addiction. J Am Osteopath Assoc. 1999; 99 (9): 456.

  33. Carroll KM, Onken LS. Behavioral therapies for drug abuse. Am J Psychiatry. 2005; 162 (8): 1452-1460.

  34. Roozen HG, de Waart R, van der Kroft P. Community reinforcement and family training: an effective option to engage treatment-resistant substance-abusing individuals in treatment. Addiction. 2010; 105 (10): 1729-1738.

  35. Souza y Machorro M, Cruz-Moreno DL. Acerca de la rehabilitación en adicciones. Rev Mex Neuroci. 2008; 9 (5): 409-417.

  36. Souza y Machorro M. De la resiliencia a la reintegración social del paciente dual. Revista APM Psiquiatría. Órgano oficial de la Asociación Psiquiátrica Mexicana, A.C. Época 1, 2017. En prensa.

  37. Unikel C, Ortíz A, Vazquez L. El consumo de sustancias psicotrópicas según los registros del Hospital Federal de Toxicómanos: fragmentos de historia de la farmacodependencia en México (1931-1948). Rev ABP-APAL. 1995; 17 (3): 102- 106.

  38. Klamen DL, Miller NS. Integration in education for addiction medicine. J Psychoactive Drugs. 1997; 29 (3): 263-268.

  39. Klamen DL. Education and training in addictive diseases. Psychiatr Clin North Am. 1999; 22 (2): 471-480, xi.

  40. Renner JA Jr. How to train residents to identify and treat dual diagnosis patients. Biol Psychiatry. 2004; 56 (10): 810-816.

  41. Monti PM, Rohsenow DJ, Swift RM, Gulliver SB, Colby SM, Mueller TI et al. Naltrexone and cue exposure with coping and communication skills training for alcoholics: treatment process and 1-year outcomes. Alcohol Clin Exp Res. 2001; 25 (11): 1634-1647.

  42. Sholomskas DE, Syracuse-Siewert G, Rounsaville BJ, Ball SA, Nuro KF, Carroll KM. We don’t train in vain: a dissemination trial of three strategies of training clinicians in cognitive-behavioral therapy. J Consult Clin Psychol. 2005; 73 (1): 106-115.

  43. Warburg MM, Cleary PD, Rohman M, Barnes HN, Aronson M, Delbanco TL. Residents’ attitudes, knowledge, and behavior regarding diagnosis and treatment of alcoholism. J Med Educ. 1987; 62 (6): 497-503.

  44. Souza y Machorro M. El papel de la mitología popular, la semántica y la iatrogenia en las adicciones. Rev Mex Neuroci. 2001; 2 (1): 25-27.

  45. Souza y Machorro M. Cannabis y salud: del mito a la evidencia. México: Editorial Alfil; 2017.

  46. Diario Oficial. Norma Oficial Mexicana NOM 028-SSA2-2009, Para la prevención, tratamiento y control de las adicciones. 7 de enero de 2013. Rev. Agosto, 2017.

  47. Diario Oficial. Norma Oficial Mexicana NOM-025- SSA2-2014, Para la integración de la prestación de servicios de salud en unidades de atención integral hospitalaria médicopsiquiátrica. 2014. Viernes 4 de Septiembre de 2015. Rev. Agosto, 2017.

  48. Diario Oficial. Proyecto de Norma Oficial Mexicana NOM- 168-SSA1-2012 del expediente clínico. Miércoles 30 de noviembre de 2016. Rev. Agosto, 2017.

  49. Zuccoli G, Pipitone N. Neuroimaging findings in acute Wernicke’s encephalopathy: review of the literature. AJR Am J Roentgenol. 2009; 192 (2): 501-508.

  50. Zuccoli G, Siddiqui N, Cravo I, Bailey A, Gallucci M, Harper CG. Neuroimaging findings in alcohol-related encephalopathies. AJR Am J Roentgenol. 2010; 195 (6): 1378-1384.

  51. Geibprasert S, Gallucci M, Krings T. Alcohol-induced changes in the brain as assessed by MRI and CT. Eur Radiol. 2010; 20 (6): 1492-1501.

  52. ONUDD. Oficina de las Naciones Unidas Contra la Droga y el Delito, Abuso de sustancias psicotrópicas tratamiento y rehabilitación. Guía de planificación y aplicación. Capítulo VI. Integración efectiva de los servicios de tratamiento. Naciones Unidas. Viena. Oficina de las Naciones Unidas Contra la Droga y el Delito. 2003a.

  53. ONUDD. Tratamiento contemporáneo del abuso de sustancias psicotrópicas: análisis de las pruebas científicas. ONU. New York. Oficina de las Naciones Unidas Contra la Droga y el Delito. 2003b.

  54. Rassool GH. Addiction: global problem and global response. Complacency or commitment. J Adv Nurs. 2000; 32 (3): 505- 507.

  55. UNODC’s Treatment and Rehabilitation Toolkit. National Association of Drug Court Professionals (United States) 2015. Rev. Agosto, 2017. Available in: www.unodc.org/odccp/ treatmenttoolkit.html

  56. McLellan AT, McKay JR, Forman R, Cacciola J, Kemp J. Reconsidering the evaluation of addiction treatment: from retrospective follow-up to concurrent recovery monitoring. Addiction. 2005; 100 (4): 447-458.

  57. Patra J, Taylor B, Irving H, Roerecke M, Baliunas D, Mohapatra S et al. Alcohol consumption and the risk of morbidity and mortality for different stroke types--a systematic review and meta-analysis. BMC Public Health. 2010; 10: 258.

  58. Asociación Mundial de Psiquiatría. Médicos, Pacientes, Sociedad. Derechos Humanos y Responsabilidad Profesional de los Médicos. Buenos Aires: AMP; 1998.

  59. WHO. Human rights and legislation who resource book on mental health. Geneva: World Health Organization; 2005.

  60. Godley MD, Godley SH, Dennis ML, Funk RR, Passetti LL. The effect of assertive continuing care on continuing care linkage, adherence and abstinence following residential treatment for adolescents with substance use disorders. Addiction. 2007; 102 (1): 81-93.

  61. Spanagel R, Zieglgänsberger W. Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes. Trends Pharmacol Sci. 1997; 18 (2): 54-59.

  62. Dunn J. Lead consultant in substance misuse. Adherence to substitute opioid prescribing: survey of inner-London drug services. Psychiatric Bulletin. The Royal College of Psychiatrists. 2009; 33: 336-340.

  63. Consejo Ejecutivo, 126. Estrategias para reducir el uso nocivo del alcohol: proyecto de estrategia mundial: informe de la Secretaría. Organización Mundial de la Salud. (2010) Disponible en: http://www.who.int/iris/handle/10665/2643.

  64. American College of Physicians. Health and Public Policy committee. Chemical dependence. Ann Int Med. 1985; 102 (3): 405-408.

  65. National Institute on Drug Abuse. Principles of Adolescent Substance Use Disorder Treatment: A Research-Based Guide 2011. Available in: www.drugabuse.gov/publications/ principles-adolescent-substance-use-disorder-treatmentresearch- based-guide/frequentlyaskedquestions /how-canparents- participate-in-their-adolescent-childs-treatment [Revisado Agosto, 2017]

  66. National Institute on Drug Abuse. Marijuana Facts: Parents Need to Know. May 27, 2014. Available in: www.drugabuse. gov/publications/marijuana-facts-parents-need-to-know [Rev. Agosto, 2017]

  67. Jainchill N, Hawke J, Messina M. Post-treatment outcomes among adjudicated adolescent males and females in modified therapeutic community treatment. Subst Use Misuse. 2005; 40 (7): 975-996.

  68. Foster M, Nathan S, Ferry M. The experience of drugdependent adolescents in a therapeutic community. Drug Alcohol Rev. 2010; 29 (5): 531-539.

  69. McCaffery M, Pasero CL. Talking with patients and families about addiction. Am J Nurs. 1998; 98 (3): 18-21.

  70. American Psychiatric Association. Diagnostical and statistical manual of mental disorders (DSM-IV-TR). 4th edition. Washington: APA; 2000.

  71. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th edition. DSM_5. Arlington: American Psychiatric Association; 2013.

  72. Souza y Machorro M. Investigación y enseñanza en adicciones en la Ciudad de México. Psiquiatría. 1998; 14 (3): 100-106.

  73. Ríos-Lago M. Functional magnetic resonance and neuropsychology: basic concepts. Radiologia. 2008; 50 (5): 351-365; quizz 365.

  74. Schuckit MA. Alcohol-use disorders. Lancet. 2009; 373 (9662): 492-501.

  75. Matochik J. Alcoholism Research and Neuroimaging: Implications for Treatment. Neuro-psychiatry, Addiction, Alcohol Abuse. Psychiatric News, APA. March 07, 2013.

  76. Edwards G, Arif A, Hadgson R. Nomenclature and classification of drug- and alcohol-related problems: a WHO Memorandum. Bull World Health Organ. 1981; 59 (2): 225-242.

  77. Schuckit MA, Smith TL, Heron J, Hickman M, Macleod J, Munafo MR et al. Latent trajectory classes for alcohol-related blackouts from age 15 to 19 in ALSPAC. Alcohol Clin Exp Res. 2015; 39 (1): 108-116.

  78. Souza y MM, Díaz BS, Guisa CV. Adicciones: neuroquímica y terapéutica. Rev Mex Neuroci. 2004; 5 (6): 619-625.

  79. Souza y MM. Patología dual: trastornos adictivos y patología psicosexual en HLBT. Diseño y tecnología. 1a reimpresión. México: Editorial Prado; 2017.

  80. Kessler RC. The World Health Organization International Consortium in Psychiatric Epidemiology (ICPE): initial work and future directions -- the NAPE Lecture 1998. Nordic Association for Psychiatric Epidemiology. Acta Psychiatr Scand. 1999; 99 (1): 2-9.

  81. Fried PA, Makin JE. Neonatal behavioural correlates of prenatal exposure to marihuana, cigarettes and alcohol in a low risk population. Neurotoxicol Teratol. 1987; 9 (1): 1-7.

  82. Frances RJ. Clinical textbook of addictive disorders. 3rd edition. New York: Guilford Press; 2005.

  83. Richardson GA, Ryan C, Willford J, Day NL, Goldschmidt L. Prenatal alcohol and marijuana exposure: effects on neuropsychological outcomes at 10 years. Neurotoxicol Teratol. 2002; 24 (3): 309-320.

  84. DeWit DJ, Adlaf EM, Offord DR, Ogborne AC. Age at first alcohol use: a risk factor for the development of alcohol disorders. Am J Psychiatry. 2000; 157 (5): 745-750.

  85. Flory K, Lynam D, Milich R, Leukefeld C, Clayton R. Early adolescent through young adult alcohol and marijuana use trajectories: early predictors, young adult outcomes, and predictive utility. Dev Psychopathol. 2004; 16 (1): 193-213.

  86. Adger H. Children in alcoholic families: family dynamics and treatment issues. In: Abbott S (Ed.). Children of alcoholics. Selected readings. Volume II. Rockville, MD: National Association of Children of Alcoholics; 2000. pp. 235-242.

  87. Gavriel-Fried B, Teichman M. Ego identity of adolescent children of alcoholics. J Drug Educ. 2007; 37 (1): 83-95.

  88. Ledoux S, Miller P, Choquet M, Plant M. Family structure, parent-child relationships, and alcohol and other drug use among teenagers in France and the United Kingdom. Alcohol Alcohol. 2002; 37 (1): 52-60.

  89. Souza y Machorro M. Dinámica y evolución de la vida en pareja. 2a ed. LAP. Lambert Academic Pub. Saarbrücken, Germany: Editorial Académica Española; 2012.

  90. Eigen LD, Rowden DW. A methodology and current estimate of the number of children of alcoholics in the United States. In: Abbott S (Ed.). Children of alcoholics, selected readings. Rockville, MD: National Association of Children of Alcoholics; 2000. pp. 1-21.

  91. Schuckit MA, Smith TL. Correlates of unpredicted outcomes in sons of alcoholics and controls. J Stud Alcohol. 2001; 62 (4): 477-485.

  92. Murphy CM, Ting L. The effects of treatment for substance use problems on intimate partner violence: a review of empirical data. Aggress Violent Beh. 2010; 15: 325-333.

  93. Suelves JM, Jané M, Plasencia A. Violencia del compañero íntimo contra la mujer: una mirada desde la Salud Pública. Rev Esp Med Legal. 2010; 36 (3): 98-103.

  94. Lawoko S, Sanz S, Helström L, Castren M. Screening for intimate partner violence against women in healthcare sweden: prevalence and determinants. ISRN Nurs. 2011; 2011: 510692.

  95. Boles SM, Miotto K. Substance abuse and violence: a review of the literature. Aggression Violent Behav. 2003; 8 (2): 155-174.

  96. Arroyo K, Lundahl B, Butters R, Vanderloo M, Wood DS. Shortterm interventions for survivors of intimate partner violence: a systematic review and meta-analysis. Trauma Violence Abuse. 2015 Sep 2. pii: 1524838015602736. [Epub ahead of print]

  97. DeLisi M, Vaughn MG, Salas-Wright C, Jennings WG. Drugged and dangerous: prevalence and variants of substance use comorbidity among seriously violent offenders in the united states. J Drug Issues. 2015; 45 (3): 232-248.

  98. Jackson V, Chou S, Browne K. Protective factors against child victimization in the school and community: an exploratory systematic review of longitudinal predictors and interacting variables. Trauma Violence Abuse. 2015 Oct 22. pii: 1524838015611675. [Epub ahead of print]

  99. Cohen JA, Mannarino AP, Zhitova AC, Capone ME. Treating child abuse-related posttraumatic stress and comorbid substance abuse in adolescents. Child Abuse Negl. 2003; 27 (12): 1345-1365.

  100. Dennis ML, White M, Ives MI. Individual characteristics and needs associated with substance misuse of adolescents and young adults in addiction treatment. In: Leukefeld C, Gullotta T, Tindall ST (eds). Handbook on adolescent substance abuse prevention and treatment: evidence-based practice. New London, CT: Child & Family Agency Press; 2009.

  101. Souza y Machorro M. Abuso de menores y violencia sexual en la sociedad actual. Revista APM Psiquiatría. 2015; 2 (3): 28-38.

  102. Grann M, Fazel S. Substance misuse and violent crime: Swedish population study. BMJ. 2004; 328 (7450): 1233-1234.

  103. WHO. Compendium of united nations standards and norms in crime prevention. New York: World Health Organization; 2006b. Rev. Agosto, 2017.

  104. Ronen A, Gershon P, Drobiner H, Rabinovich A, Bar-Hamburger R, Mechoulam R et al. Effects of THC on driving performance, physiological state and subjective feelings relative to alcohol. Accid Anal Prev. 2008; 40 (3): 926-934.

  105. Hibell B, Guttormsson U, Ahlström S et al. The 2011 ESPAD Report-substance use among students in 36 European countries. 2009. Stockholm. The Swedish Council for Information on Alcohol and Other Drugs. 2012. Available in: www.espad.org/documents/Espad /ESPAD_reports/2009/ The_2009_ ESPAD_Report-FULL0910 06. Patología dual. [Rev. Agosto, 2017]

  106. Ronen A, Chassidim HS, Gershon P, Parmet Y, Rabinovich A, Bar-Hamburger R et al. The effect of alcohol, THC and their combination on perceived effects, willingness to drive and performance of driving and non-driving tasks. Accid Anal Prev. 2010; 42 (6): 1855-1865.

  107. Guisa CVM, Díaz-Barriga SL, Souza y Machorro M. A propósito de la relación entre adicciones y delincuencia. Psiquiatría. 2003; 19 (1): 14-27.

  108. AIC. Policy Series, No. 90. Australian Institute of Criminology. Canberra, 2008. Available in: www.aic.gov.au/documents/4/1/ E/%7B41EFB68A-8B0A-43F8A747E71315F88751%7Drpp 90. Patología dual. [Rev. Agosto, 2017]

  109. Beynon CM, McVeigh C, McVeigh J, Leavey C, Bellis MA. The involvement of drugs and alcohol in drug-facilitated sexual assault: a systematic review of the evidence. Trauma Violence Abuse. 2008; 9 (3): 178-188.

  110. Beynon C, McVeigh J, Hurst A, Marr A. Older and sicker: Changing mortality of drug users in treatment in the North West of England. Int J Drug Policy. 2010; 21 (5): 429-431.

  111. Mason W, Kosterman R, Hawkins J, Haggerty KP, Spoth RL. Reducing adolescents’ growth in substance use and delinquency: randomized trial effects of a parent-training prevention intervention. Prev Sci. 2003; 4 (3): 203-212.

  112. Young R, Sweeting H, West P. A longitudinal study of alcohol use and antisocial behaviour in young people. Alcohol Alcohol. 2008; 43 (2): 204-214.

  113. Griffiths CT, Dandur Y, Murdoch D. The social reintegration of offenders and crime prevention. Ottawa: Public Safety Canada, National Crime Prevention Centre; 2007. Available in: www. publicsafety.gc.ca/res/cpres/fl/soc-reint-eng.patologíadualf. [Revisado Agosto, 201]

  114. ONUDD. Oficina de las Naciones Unidas contra la droga y el delito. Yury Fedotov Director Ejecutivo, Informe Mundial sobre las Drogas 2017. Geneva: 2017.

  115. ENA. Encuesta Nacional de Consumo de Drogas, Alcohol y Tabaco 2016-2017. Resultados preliminares. Disponible en: noticieros.televisa.com/.../nacional/2017 [26 jun. 2017]

  116. Souza y Machorro M. El lenguaje en la salud y la patología dual. VII Congreso Internacional y X Congreso Nacional. Academia Nacional Mexicana de Bioética. Auditorio de la Policlínica Ángel Urraza. Sociedad de Beneficencia Española. Hospital Español de México. Octubre 15-17, 2015.

  117. Souza y Machorro M. El papel del lenguaje en el manejo profesional de la patología dual. Revista APM Psiquiatría. Órgano Oficial de la Asociación Psiquiátrica Mexicana, A.C. 2017. En Prensa.

  118. Pullen LM, Green LA. Identification, intervention and education: essential curriculum components for chemical dependency in nurses. J Contin Educ Nurs. 1997; 28 (5): 211-216.

  119. DrugScope. The media guide to drugs: key facts and figures for journalists. London: DrugScope; 2011.

  120. Rhoades E, Jernigan DH. Risky messages in alcohol advertising, 2003-2007: results from content analysis. J Adolesc Health. 2013; 52 (1): 116-121.

  121. Souza y Machorro M. Palabras para la presentación del libro políticas sobre el cannabis. En: Room R, Fischer B, Hall W, Lenton S, Reuter L, Corda RA et al. México: Editorial Fondo de Cultura Económica; 2013. V Feria Internacional del Libro De Minería (FILPM). Galería de los Rectores. Palacio de Minería de la Facultad de Ingeniería. Universidad Nacional Autónoma De México, UNAM; Ciudad de México. Febrero 22, 2014.

  122. National Institute on Drug Abuse. Drugs, brains, and behavior: the science of addiction. 2010. NIH Pub. No. 10-5605. Available in: www.drugabuse.gov/publications /scienceaddiction. [Rev. Agosto, 2017]

  123. de Silva V, Samarasinghe D, Hanwella R. Association between concurrent alcohol and tobacco use and poverty. Drug Alcohol Rev. 2011; 30 (1): 69-73.

  124. Souza y Machorro M. Evaluación clínica del paciente adicto comórbido. Revista Electrónica de Medicina Neuropsicológica. 2013; 14 (2): 455-468.

  125. Attwell D, Buchan AM, Charpak S, Lauritzen M, Macvicar BA, Newman EA. Glial and neuronal control of brain blood flow. Nature. 2010; 468 (7321): 232-243.

  126. Pedrero-Pérez EJ, Rojo-Mota G, Ruiz-Sánchez de León JM, Llanero-Luque M, Puerta-García C. Rehabilitación cognitiva en el tratamiento de las adicciones. Rev Neurol. 2011; 52 (3): 163-172.

  127. Zhou W. Normalizing drug-induced neuronal plasticity in nucleus accumbens weakens enduring drug-seeking behavior. Neuropsychopharmacology. 2010; 35 (1): 352-353.

  128. Andero R, Heldt SA, Ye K, Liu X, Armario A, Ressler KJ. Effect of 7,8-dihydroxyflavone, a small-molecule TrkB agonist, on emotional learning. Am J Psychiatry. 2011; 168 (2): 163-172.

  129. Kantak KM, Hofmann SG. Cognitive enhancers for the treatment of neuropsychiatric disorders: clinical and preclinical investigations. Pharmacol Biochem Behav. 2011; 99 (2): 113- 115.

  130. Lorea-Conde I, Tirapu-Ustárroz J, Landa N, López-Goñi JJ. Deshabituación de sustancias psicotrópicas y funcionamiento cerebral: una visión integradora. Adicciones. 2005; 17 (2): 121-129.

  131. Marlatt GA. La prevención de recaídas en las conductas adictivas: un enfoque de tratamiento cognitivo-conductual. En Gossop M, Casas M (eds.). Recaída y prevención de recaídas. Barcelona: Ed. Neurociencias; 1993.

  132. Pedrero-Pérez EJ, Pérez-López M, Ena de la Cuesta S, Garrido- Caballero C. Validación del cuestionario de variables de interacción psicosocial (VIP): hacia un modelo de tratamiento de las conductas adictivas “guiado por la personalidad”. Trastornos Adictivos. 2005; 7 (3): 166-186.

  133. Pedrero-Pérez EJ, Puerta-García C, Olivar-Arroyo A. La enfermedad como barrera al tratamiento. Trastornos Adictivos. 2007; 9 (3): 161-168.

  134. Pedrero-Pérez EJ, Puerta-García C, Segura-López I, Osorio del Río SM. Evolución de la sintomatología psicopatológica de los drogodependientes a lo largo del tratamiento. Trastornos Adictivos. 2004; 6 (3): 176-191.

  135. Davis C, Loxton NJ. Addictive behaviors and addiction-prone personality traits: associations with a dopamine multilocus genetic profile. Addict Behav. 2013; 38 (7): 2306-2312.

  136. Llanero-Luque M, de León JM, Pedrero-Pérez EJ, Olivar- Arroyo A, Bouso-Saiz JC, Rojo-Mota G et al. Sintomatología disejecutiva en adictos a sustancias en tratamiento mediante la versión española del cuestionario disejecutivo (DEX-Sp). Rev Neurol. 2008; 47 (9): 457-463.

  137. Busch FN, Milrod BL, Sandberg LS. A study demonstrating efficacy of a psychoanalytic psychotherapy for panic disorder: implications for psychoanalytic research, theory, and practice. J Am Psychoanal Assoc. 2009; 57 (1): 131-148.

  138. Shafii M, Steltz-Lenarsky J, Derrick AM, Beckner C, Whittinghill JR. Comorbidity of mental disorders in the post-mortem diagnosis of completed suicide in children and adolescents. J Affect Disord. 1988; 15 (3): 227-233.

  139. Compton WM, Thomas YF, Stinson FS, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2007; 64 (5): 566-576.

  140. Compton RP, Berning A. Drug and alcohol crash risk. Washington, DC: National Highway Traffic Safety Administration; 2015. DOT HA 812 117.

  141. Souza y Machorro M. Filosofía y políticas de los programas terapéuticos contra las adicciones. En: Souza y Machorro M. Psiquiatría de las Adicciones. México: Fondo de Cultura Económica; 2010.

  142. Rehm J, Baliunas D, Borges GL, Graham K, Irving H, Kehoe T et al. The relation between different dimensions of alcohol consumption and burden of disease: an overview. Addiction. 2010; 105 (5): 817-843.

  143. Rehm J, Taylor B, Mohapatra S, Irving H, Baliunas D, Patra J et al. Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis. Drug Alcohol Rev. 2010; 29 (4): 437-445.

  144. Rehm J, Kanteres F, Lachenmeier DW. Unrecorded consumption, quality of alcohol and health consequences. Drug Alcohol Rev. 2010; 29 (4): 426-436.

  145. Stanger C, Budney AJ. Contingency management approaches for adolescent substance use disorders. Child Adolesc Psychiatr Clin N Am. 2010; 19 (3): 547-562.

  146. Souza y Machorro M. De la resiliencia a la reintegración social del paciente dual. Seminario “Prevención y rehabilitación de las adicciones”. Maestría en Psicoterapia de las Adicciones. Colegio Internacional de Educación Superior, CIES/SEP. México, D.F. Mayo 31, 2015.

  147. Souza y Machorro M. Obstáculos y recomendaciones para el tratamiento de abusadores/dependientes a sustancias psicotrópicas. Rev Mex Neuroci. 2009; 10 (5): 350-359.

  148. American Medical Association. Council on Mental Health and Committee on Alcoholism and Drug Dependency. Medical school education on abuse on alcoholism and other psychoactive drugs. JAMA. 1972; 219 (13): 1746-1749.

  149. Souza y Machorro M. Educación, salud y adicciones. Rev Mex Neuroci. 2003; 4 (2): 91-93.

  150. Galanter M, Keller DS, Dermatis H, Biderman D. Use of the Internet for addiction education. Combining network therapy with pharmacotherapy. Am J Addict. 1998; 7 (1): 7-13.

  151. Dove HW. Postgraduate education and training in addiction disorders. Defining core competencies. Psychiatr Clin North Am. 1999; 22 (2): 481-488, xi.

  152. Bland E, Oppenheimer L, Brisson-Carroll G, Morel C, Holmes P, Gruslin A. Influence of an educational program on medical students’ attitudes to substance use disorders in pregnancy. Am J Drug Alcohol Abuse. 2001; 27 (3): 483-490.

  153. Gabbard GO. Long-term psychodynamic psychotherapy: a basic text. Washington: American Publishing Press; 2010.

  154. US Department of Health and Human Service, Healthy People 2010: Understanding and Improving Health 2nd. ed. Washington, DC US Dept of Health and Human Services November, 2010.

  155. Millán S. El psicoanálisis contemporáneo. Simposio de la Federación Internacional de Sociedades Psicoanalíticas IFPS e Instituto Mexicano de Psicoanálisis A. C. XVII Congreso Nacional de la Asociación Psiquiátrica Mexicana A.C. y Simposio Regional de la Asociación Psiquiátrica de América Latina. Cancún Q. Roo, Noviembre 16-20, 2001.

  156. Fromm E. El arte de amar: una investigación sobre la naturaleza del amor. México: Colección Contextos; 2003.

  157. Levy R, Ablon JS. Handbook of evidence-based psychodynamic psychotherapy: bridging the gap between science and practice. Boston: Humana Press; 2009.




2020     |     www.medigraphic.com